Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of artemisinin in preparation of drugs for resisting human liver cancer HepG2 and Huh7 cells

An artemisinin and cell technology, applied in antitumor drugs, drug combinations, pharmaceutical formulations, etc., can solve the problems of difficulty in early detection of HCC and low survival rate of HCC patients

Inactive Publication Date: 2019-08-23
SOUTHERN MEDICAL UNIVERSITY
View PDF1 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Despite great achievements in novel therapeutics and diagnostic techniques, early detection of HCC is difficult, resulting in a low 5-year survival rate (0-14%) for HCC patients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of artemisinin in preparation of drugs for resisting human liver cancer HepG2 and Huh7 cells
  • Application of artemisinin in preparation of drugs for resisting human liver cancer HepG2 and Huh7 cells
  • Application of artemisinin in preparation of drugs for resisting human liver cancer HepG2 and Huh7 cells

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0053] The artemisinin medicine is made into granules, and the preparation method is as follows:

[0054] 1) Take 50g of artemisinin, add water and decoct twice, the first time for 2 hours, the second time for 1 hour, combine the decoction, filter, and concentrate the filtrate to an appropriate amount (about 50mL);

[0055] 2) Add ethanol to make the alcohol content 60%, stir while adding, let it stand for precipitation, take the supernatant to recover ethanol, concentrate to a clear paste with a relative density of 1.30-1.33 (80°C) (about 1:4, That is, 1 part of clear ointment is equivalent to 4 parts of medicinal materials);

[0056] 3) Add 20g of a mixture of sugarcane powder and dextrin (sucrose:dextrin=3:1) and 10ml of 70% ethanol, mix to form soft powder, squeeze and sieve (12-14 mesh) to make granules;

[0057] 4) Dried at 60°C, granulated, packed in plastic bags equivalent to 10 g of artemisinin per bag, and sealed to obtain artemisinin granules.

[0058] Dosage meth...

Embodiment 2

[0061] The artemisinin medicine is made into capsules, and the preparation method is as follows:

[0062] 1) Take 25 g of artemisinin and pulverize it into a coarse powder, reflux with 95% ethanol for 1 hour, and filter; then reflux the dregs with 50% ethanol for 1.5 hours, filter, combine the filtrates, and recover ethanol;

[0063] 2) Decoct the dregs with water for 2 hours, filter, combine the decoction and filtrate, and concentrate until syrupy;

[0064] 3) Add 10g of starch and mix well, add an appropriate amount of starch slurry, mix to make soft powder, press through a 80-100 mesh sieve to granulate, dry at 60-70°C, and granulate;

[0065] 4) Add 0.15 g of magnesium stearate, mix well, and pack into capsules to obtain artemisinin capsules.

[0066] Administration method: Oral, 1 to 2 times a day, 1 to 2 capsules each time, suitable for consumption on an empty stomach. Those with sensitive stomachs, please take with meals.

[0067] Precautions: Keep out of reach of ch...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of artemisinin in preparation of drugs for resisting human liver cancer HepG2 and Huh7 cells. The purpose is achieved by inhibiting proliferation of the human livercancer HepG2 and Huh7 cells, and / or adjusting the expression profile of miRNA in the human liver cancer HepG2 and Huh7 cells. The concentration of the artemisinin is lower than or equal to 100 micromoles; the drugs are in an electuary dosage form or a capsule dosage form. The invention further discloses a drug electuary which contains the artemisinin and resists the human liver cancer HepG2 and Huh7 cells, a drug capsule which contains the artemisinin and resists the human liver cancer HepG2 and Huh7 cells and preparation method of the drug capsule. Under the effect of the artemisinin drugs,the proliferation of the human liver cancer HepG2 and Huh7 cells is inhibited, changes of the expression profile of the miRNA in the human liver cancer HepG2 and Huh7 cells are adjusted and controlled, the miRNA potentially adjusting and controlling the liver cancer is discovered, and the foundation is laid for strategic development of the artemisinin in the aspect of liver cancer treatment.

Description

technical field [0001] The invention relates to the application of artemisinin in the preparation of anti-human liver cancer HepG2 and Huh7 cell medicines, belonging to the technical field of biopharmaceuticals. The medicine can inhibit the proliferation of human liver cancer HepG2 cells and Huh7 cells and regulate the miRNA expression profile of human liver cancer HepG2 cells and Huh7 cells. Background technique [0002] Hepatocellular carcinoma (HCC) is one of the most common malignant tumors, accounting for 90% of primary liver cancers. Despite great achievements in novel therapeutics and diagnostic techniques, early detection of HCC is difficult, resulting in a low 5-year survival rate (0-14%) for HCC patients. Therefore, it is crucial to discover specific and sensitive biomarkers that can identify HCC. Artemisia annua is an important Chinese herbal medicine. Artemisinin, extracted from the herb Artemisia annua, is an active ingredient in antimalarial drugs. In recent...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/366A61K9/16A61K9/48A61K47/36A61P35/00
CPCA61K9/0095A61K9/1652A61K31/366A61P35/00
Inventor 杨加顺唐玲袁立霞谭晓梅罗佳波汤庆发陈飞龙邢学锋
Owner SOUTHERN MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com